Performance of cardiopulmonary exercise testing for the prediction of post-operative complications in non cardiopulmonary surgery: A systematic review.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 04 09 2019
accepted: 24 11 2019
entrez: 4 2 2020
pubmed: 6 2 2020
medline: 6 5 2020
Statut: epublish

Résumé

Cardiopulmonary exercise testing (CPET) is widely used within the United Kingdom for preoperative risk stratification. Despite this, CPET's performance in predicting adverse events has not been systematically evaluated within the framework of classifier performance. After prospective registration on PROSPERO (CRD42018095508) we systematically identified studies where CPET was used to aid in the prognostication of mortality, cardiorespiratory complications, and unplanned intensive care unit (ICU) admission in individuals undergoing non-cardiopulmonary surgery. For all included studies we extracted or calculated measures of predictive performance whilst identifying and critiquing predictive models encompassing CPET derived variables. We identified 36 studies for qualitative review, from 27 of which measures of classifier performance could be calculated. We found studies to be highly heterogeneous in methodology and quality with high potential for bias and confounding. We found seven studies that presented risk prediction models for outcomes of interest. Of these, only four studies outlined a clear process of model development; assessment of discrimination and calibration were performed in only two and only one study undertook internal validation. No scores were externally validated. Systematically identified and calculated measures of test performance for CPET demonstrated mixed performance. Data was most complete for anaerobic threshold (AT) based predictions: calculated sensitivities ranged from 20-100% when used for predicting risk of mortality with high negative predictive values (96-100%). In contrast, positive predictive value (PPV) was poor (2.9-42.1%). PPV appeared to be generally higher for cardiorespiratory complications, with similar sensitivities. Similar patterns were seen for the association of Peak VO2 (sensitivity 85.7-100%, PPV 2.7-5.9%) and VE/VCO2 (Sensitivity 27.8%-100%, PPV 3.4-7.1%) with mortality. In general CPET's 'rule-out' capability appears better than its ability to 'rule-in' complications. Poor PPV may reflect the frequency of complications in studied populations. Our calculated estimates of classifier performance suggest the need for a balanced interpretation of the pros and cons of CPET guided pre-operative risk stratification.

Identifiants

pubmed: 32012165
doi: 10.1371/journal.pone.0226480
pii: PONE-D-19-24934
pmc: PMC6996804
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0226480

Subventions

Organisme : Wellcome Trust
ID : 204017/Z/16/Z
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Chest. 1999 Aug;116(2):355-62
pubmed: 10453862
JAMA. 2003 May 21;289(19):2554-9
pubmed: 12759327
Perioper Med (Lond). 2013 Feb 25;2(1):4
pubmed: 24472647
Br J Anaesth. 2019 Aug;123(2):238-245
pubmed: 30916023
Br J Anaesth. 2016 Feb;116(2):177-91
pubmed: 26787788
Br J Anaesth. 2010 Sep;105(3):297-303
pubmed: 20573634
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215
Br J Anaesth. 2014 Apr;112(4):665-71
pubmed: 24322573
Eur J Vasc Endovasc Surg. 2012 Jul;44(1):64-71
pubmed: 22521839
Chest. 2006 Aug;130(2):517-25
pubmed: 16899853
PLoS One. 2013 May 27;8(5):e64335
pubmed: 23724043
Br J Surg. 2012 Aug;99(8):1097-104
pubmed: 22696424
ANZ J Surg. 2008 Jan-Feb;78(1-2):24-7
pubmed: 18199201
Aliment Pharmacol Ther. 2016 Oct;44(8):796-806
pubmed: 27539029
Colorectal Dis. 2016 Jun;18(6):578-85
pubmed: 26417705
Ann R Coll Surg Engl. 2013 Mar;95(2):125-30
pubmed: 23484995
Br J Surg. 2016 May;103(6):744-752
pubmed: 26914526
Br J Anaesth. 2014 Mar;112(3):491-7
pubmed: 24148323
Inhal Toxicol. 2014 Nov;26(13):811-28
pubmed: 25264934
J Thorac Cardiovasc Surg. 2001 Jun;121(6):1064-8
pubmed: 11385372
Ann Surg. 2013 Jun;257(6):999-1004
pubmed: 23665968
HPB (Oxford). 2013 Nov;15(11):899-907
pubmed: 23458160
Ann R Coll Surg Engl. 2011 Sep;93(6):474-81
pubmed: 21929919
BJU Int. 2013 Jul;112(2):E13-9
pubmed: 23795790
Br J Anaesth. 2018 Oct;121(4):730-738
pubmed: 30236235
Circulation. 2010 Jul 13;122(2):191-225
pubmed: 20585013
Neurooncol Pract. 2015 Dec;2(4):162-166
pubmed: 31386059
Surgery. 2019 Jul;166(1):28-33
pubmed: 30981415
Br J Anaesth. 2018 Mar;120(3):419-421
pubmed: 29452793
Anaesthesia. 2015 Jun;70(6):679-85
pubmed: 25656939
Eur J Surg Oncol. 2018 May;44(5):594-599
pubmed: 29459017
Eur J Anaesthesiol. 2015 Feb;32(2):88-105
pubmed: 25058504
Ann R Coll Surg Engl. 2018 Sep;100(7):515-519
pubmed: 29692190
Curr Anesthesiol Rep. 2018;8(1):1-8
pubmed: 29527132
Br J Anaesth. 2008 Dec;101(6):774-80
pubmed: 18953057
Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S53-S58
pubmed: 28362512
J Surg Oncol. 2014 Sep;110(4):439-44
pubmed: 24894657
PLoS Med. 2014 Oct 14;11(10):e1001744
pubmed: 25314315
Ann Thorac Surg. 2008 Jan;85(1):294-9
pubmed: 18154826
Br J Surg. 2012 Nov;99(11):1539-46
pubmed: 23001820
Ir J Med Sci. 1998 Oct-Dec;167(4):238-41
pubmed: 9868863
Eur J Surg Oncol. 2014 Nov;40(11):1421-8
pubmed: 24784775
Ann Surg Oncol. 2014 Jun;21(6):1929-36
pubmed: 24477709
Lancet. 2018 Jun 30;391(10140):2631-2640
pubmed: 30070222
Br J Anaesth. 2019 Jul;123(1):17-26
pubmed: 31029407
Br J Surg. 2012 Sep;99(9):1290-4
pubmed: 22828960
Eur J Vasc Endovasc Surg. 2017 Aug;54(2):212-219
pubmed: 28625356
Ann Intern Med. 2013 Feb 19;158(4):280-6
pubmed: 23420236
Chest. 1993 Sep;104(3):701-4
pubmed: 8365279
Perioper Med (Lond). 2013 May 19;2(1):10
pubmed: 24472159
Ann Surg. 2010 Mar;251(3):535-41
pubmed: 20134313
Br J Anaesth. 2013 Oct;111(4):607-11
pubmed: 23744818

Auteurs

Daniel J Stubbs (DJ)

University Division of Anaesthesia, Department of Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, Cambridge, United Kingdom.

Lisa A Grimes (LA)

University Division of Anaesthesia, Department of Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, Cambridge, United Kingdom.

Ari Ercole (A)

University Division of Anaesthesia, Department of Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH